A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

Area of Science:

• Biochemistry
• Cell Biology
• Photodynamic Therapy

Background:

• Photodynamic therapy (PDT) is a promising cancer treatment modality.
• Enhancing the specificity and efficacy of PDT remains a critical challenge.
• Mitochondria are key targets for inducing irreversible cancer cell death.

Purpose of the Study:

• To synthesize a novel protein-conjugated photosensitizer.
• To imbue the photosensitizer with mitochondrial targeting capabilities.
• To evaluate its enhanced therapeutic potential in PDT.

Main Methods:

• Synthesis of a protein-conjugated photosensitizer.
• In vitro assessment of reactive oxygen species (ROS) generation under laser irradiation.
• Analysis of intracellular protein damage and mitochondrial function.
• Evaluation of cell viability and induction of apoptosis.

Main Results:

• The synthesized photosensitizer demonstrated efficient ROS production upon laser activation.
• Targeted delivery to mitochondria was confirmed.
• Significant disruption of mitochondrial redox homeostasis and key protein function was observed.
• Irreversible cell death was induced in cancer cells.

Conclusions:

• Protein-conjugated, mitochondrially-targeted photosensitizers represent a potent strategy for enhancing PDT.
• This approach effectively leverages ROS to induce targeted cell death via mitochondrial disruption.
• Further investigation is warranted for clinical translation of this enhanced PDT approach.